Keyphrases
Rat Model
100%
Cell-based
100%
Vaccination
100%
Neuroprotection
100%
Elevated Intraocular Pressure
100%
Copolymer-1
100%
Intraocular Pressure
60%
T-cell Mediated
40%
Self-antigens
40%
T Cells
20%
Disease Progression
20%
Beneficial Effects
20%
Therapeutic Approaches
20%
Treatment Modalities
20%
Pressure-induced
20%
Pattern Electroretinogram
20%
High Intraocular Pressure
20%
Induced Loss
20%
Chronic Model
20%
Experimental Animals
20%
Cell-mediated Response
20%
Retinal Ganglion Cell Death
20%
Glatiramer Acetate
20%
Adrenoreceptor Agonist
20%
Therapeutic Vaccination
20%
Synthetic Copolymer
20%
Therapeutic Pressure
20%
Functional Protection
20%
Chronic Glaucoma
20%
Glaucoma Progression
20%
Pressure Reduction
20%
Adjuvant-free
20%
Acute Glaucoma
20%
Immunology and Microbiology
T Cell
100%
Morphology
100%
Vaccination Policy
100%
Rat Model
100%
Glatiramer Acetate
100%
Intraocular Pressure
100%
Agonist
33%
Adjuvant
16%
Cell Death
16%
Ganglion
16%
Experimental Animal
16%
Medicine and Dentistry
T Cell
100%
Morphology
100%
Intraocular Pressure
100%
Neuroprotection
100%
Glatiramer
100%
Glaucoma
33%
Ganglion
16%
Electroretinography
16%
Cell Death
16%
Adrenergic Receptor
16%
Adjuvant
16%
Disease Exacerbation
16%
Copolymer
16%
Closed Angle Glaucoma
16%
Neuroscience
T Cell
100%
Neuroprotection
100%
Intraocular Pressure
100%
Glatiramer Acetate
100%
Agonist
33%
Glaucoma
33%
Cell Death
16%
Electroretinography
16%
Retinal Ganglion Cell
16%
Adrenergic Receptor
16%
Copolymer
16%
Pharmacology, Toxicology and Pharmaceutical Science
Rat Model
100%
Vaccination Policy
100%
Neuroprotection
100%
Glatiramer
100%
Glaucoma
33%
Adjuvant
16%
Copolymer
16%
Disease Exacerbation
16%
Adrenergic Receptor
16%
Experimental Animal
16%
Closed Angle Glaucoma
16%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Morphology
100%
Rat Model
100%
Intraocular Pressure
100%
Agonist
33%
Cell Death
16%
Experimental Animal
16%
Adrenergic Receptor
16%
Electroretinography
16%
Retinal Ganglion Cell
16%